Viewing Study NCT00616902


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-04-10 @ 8:16 PM
Study NCT ID: NCT00616902
Status: TERMINATED
Last Update Posted: 2012-01-20
First Post: 2008-02-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5
Sponsor: Abbott
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-01
Start Date Type: None
Primary Completion Date: 2009-05
Primary Completion Date Type: ACTUAL
Completion Date: 2009-05
Completion Date Type: ACTUAL
First Submit Date: 2008-02-05
First Submit QC Date: None
Study First Post Date: 2008-02-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2010-05-21
Results First Submit QC Date: None
Results First Post Date: 2010-08-04
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2012-01-18
Last Update Post Date: 2012-01-20
Last Update Post Date Type: ESTIMATED